Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study

Franco Locatelli, Bülent Antmen, Hyoung Jin Kang, Katsuyoshi Koh, Yoshiyuki Takahashi, Alphan Küpesiz, Maria Gabriela Matos, Yogi Chopra, Sunil Bhat, Ho Joon Im, Tayfun Güngör, Meng‐Yao Lu, Tommaso Stefanelli, Christine Rosko, Annie St. Pierre, K. Burock, Yvonne S. Smith, Karen Sinclair, Cristina Díaz de Heredia